Jeffrey G. Spragens
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey G. Spragens
Earlier roles on record: Board Member at SAB Biotherapeutics, Inc. (SABS) until September 30, 2025. SAB Biotherapeutics, Inc. reported in an 8-K filed September 30, 2025 that Jeffrey G. Spragens resigned as members of the Board of Directors, effective September 30, 2025.
“On September 30, 2025, Christine Hamilton and Jeffrey Spragens resigned as members of the Board of Directors (the "Board") of SAB Biotherapeutics, Inc. (the "Company") and the size of the Board was decreased from 11 to nine, in accordance with the terms of the letter agreement entered into between the Company and RA Capital Healthcare Fund, L.P., dated July 21, 2025, in connection with the Company's July 2025 private placement of securities.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-01-01–2025-09-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.